Foundayo is the first FDA-approved daily GLP-1 pill. No injections. No food or water restrictions. Physician-prescribed through pepta.
Self-pay: $149–$349/mo depending on dose
Full refund if not approved by physician.



Foundayo delivers the same GLP-1 weight loss mechanism in a simple daily pill. No injections, no food timing, no hassle.
*Eligible patients with commercial insurance using the Lilly savings card. Actual cost depends on insurance plan.
5-minute health questionnaire. Our physician reviews your profile, weight history, and goals within 24 hours.
If approved, your physician creates a personalized Foundayo dosing schedule with gradual titration to minimize side effects.
Your Foundayo prescription is sent to your preferred pharmacy or available through LillyDirect. One pill a day — no injections, no food timing.
We believe in honesty about what GLP-1 therapy involves — including side effects.
Your physician will start you at a low dose and gradually titrate up to minimize side effects. Report any adverse reactions immediately. See full prescribing information for a complete list of side effects and warnings.
Foundayo is the first FDA-approved oral GLP-1 medication for weight loss. It's a once-daily pill that works the same way as injectable GLP-1s like Wegovy and Ozempic — reducing appetite and slowing gastric emptying — but without needles, food restrictions, or water timing requirements. FDA approved April 2026 by Eli Lilly.
Foundayo is a daily pill, not a weekly injection. It uses a different molecule (orforglipron vs semaglutide) but targets the same GLP-1 receptors. Unlike Novo Nordisk's oral semaglutide, Foundayo has zero food or water restrictions — take it any time of day with or without meals.
Self-pay pricing ranges from $149/month (starting dose) to $349/month (maintenance doses) depending on your prescribed dose. With the Lilly savings card and commercial insurance, eligible patients may pay as little as $25/month. The savings card covers up to $1,000 per calendar year. Your pepta physician can help you navigate insurance and savings options.
No. Foundayo is available at self-pay pricing without insurance ($149–$349/month depending on dose). However, if you have commercial insurance that covers Foundayo, the Lilly savings card can reduce your cost to as low as $25/month. Medicare Part D patients may also qualify for $50/month starting July 2026.
None. Unlike some other GLP-1 medications that require an empty stomach and a 30-minute wait before eating, Foundayo can be taken at any time of day with or without food or water.
Foundayo is FDA-approved for adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol. Your physician will evaluate your full health profile.
Yes. We continue to offer compounded semaglutide + B12 as a budget-friendly injectable alternative starting at $149/month. However, we recommend Foundayo as our primary GLP-1 option because it's FDA-approved, oral, and insurance-eligible.
5-minute assessment. Physician review within 24 hours. Full refund if not approved.
or as low as $25/mo with insurance + Lilly savings card
Looking for our compounded semaglutide option? Starting at $149/mo →
Foundayo (orforglipron) is an FDA-approved prescription medication manufactured by Eli Lilly. Use only as prescribed by your physician. Common side effects include nausea, diarrhea, and decreased appetite. See full prescribing information for complete safety data. Results vary based on individual factors including diet and exercise. Self-pay pricing varies by dose: $149/mo (0.8 mg), $199/mo (2.5 mg), $299/mo (5.5–9 mg), $349/mo (14.5–17.2 mg). The $25/month price requires commercial insurance that covers Foundayo and the Lilly savings card. Savings card subject to maximum of $1,000/year and 10 fills/year. Not valid for patients on Medicare, Medicaid, or other government insurance. Card expires 12/31/2026. Full terms at foundayo.lilly.com. Pepta also offers compounded semaglutide + B12, which is NOT an FDA-approved finished product. Compounded medications are prepared by a licensed 503A pharmacy and are not evaluated by the FDA for safety, effectiveness, or quality.